News for Alnylam Pharmaceuticals, Inc. (0HD2.L)

Alnylam Pharmaceuticals Inc (ALNY), a leader in RNAi therapeutics, announced the retirement of Dr. Phillip A. Sharp from its Board of Directors, effective May 8

[url="]Alnylam Pharmaceuticals, Inc.[/url] (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the retirement of Dr. Phillip A. Sharp, Ph.D.

Strengths: Innovative AOC platform and robust pipeline with potential for significant market impact.Weaknesses: Lack of commercialization experience and high R

We recently published a list of 10 Oversold Biotech Stocks to Buy Now. In this article, we are going to take a look at where Alnylam Pharmaceuticals, Inc.

Start Time: 08:30 January 1, 0000 9:28 AM ETAlnylam Pharmaceuticals, Inc.

The following slide deck was published by Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Inc (ALNY), a leader in RNAi therapeutics, has released its preliminary financial results for the fourth quarter and full year 2024, sho

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance and Pipeline Goals

Alnylam Pharmaceuticals Inc (ALNY), a leader in RNAi therapeutics, announced that its management will present a company overview and participate in a Q&A sessio

[url="]Alnylam Pharmaceuticals, Inc.[/url] (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overvi

Alnylam to Webcast Presentation at 43rd Annual J.P. Morgan Healthcare Conference

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that tobevibart and elebsiran have received U.S. Food and Drug Administration (FDA) Breakthrough Therapy

There are also a bunch of companies that may be removed from the Nasdaq-100 as part of its reconstitution before the end of the year.

Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a look at where Alnylam Pharmaceuticals, Inc.

[url="]Alnylam Pharmaceuticals, Inc.[/url] (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overvi

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

As we have mentioned in our article, “10 Best Penny Stocks to Buy Under $1," the size of the global biotechnology industry was assessed to be worth $1.38 trillion in 2023 and is expected to grow at ...

Israel-based thermal energy business Brenmiller Energy Ltd (BNRG) is up over 122 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.